Table of Content

1 Introduction 5
1.1 Industry Definition and Research Scope 5
1.1.1 Industry Definition 5
1.1.2 Research Scope 6
1.2 Research Methodology 9
1.2.1 Overview of Market Research Methodology 9
1.2.2 Market Assumption 10
1.2.3 Secondary Data 10
1.2.4 Primary Data 10
1.2.5 Data Filtration and Model Design 11
1.2.6 Market Size/Share Estimation 12
1.2.7 Research Limitations 13
1.3 Executive Summary 14

2 Market Overview and Dynamics 16
2.1 Market Size and Forecast 16
2.1.1 Impact of COVID-19 on World Economy 17
2.1.2 Impact of COVID-19 on the Market 19
2.2 Major Growth Drivers 21
2.3 Market Restraints and Challenges 25
2.4 Emerging Opportunities and Market Trends 28
2.5 Porter’s Fiver Forces Analysis 32

3 Segmentation of North America Market by Treatment Type 36
3.1 Market Overview by Treatment Type 36
3.2 Medication 38
3.3 Stem Cell Therapy 40
3.4 Other Treatments 41

4 Segmentation of North America Market by ALS Type 42
4.1 Market Overview by ALS Type 42
4.2 Sporadic ALS 44
4.3 Familial ALS 45

5 Segmentation of North America Market by Distribution Channel 46
5.1 Market Overview by Distribution Channel 46
5.2 Hospital Pharmacies 48
5.3 Retail Pharmacies 49
5.4 Online Pharmacies 50
5.5 Other Distribution Channels 51

6 North America Market 2020-2027 by Country 52
6.1 Overview of North America Market 52
6.2 U.S. 55
6.3 Canada 58
6.4 Mexico 60

7 Competitive Landscape 62
7.1 Overview of Key Vendors 62
7.2 New Product Launch, Partnership, Investment, and M&A 65
7.3 Company Profiles 66
AB Science SA 66
Amylyx Pharmaceuticals Inc. 68
Biogen Inc. 69
Biohaven Pharmaceutical Holding Co., Ltd. 70
BrainStorm Cell Limited 71
Corestem, Inc. 72
F.Hoffmann-La Roche AG 73
Ionis Pharmaceuticals, Inc. 74
Mitsubishi Tanabe Pharma Corporation 75
Otsuka Pharmaceutical Co., Ltd. 76
Sun Pharmaceutical Industries Ltd. 77
RELATED REPORTS 78



List of Figures

Figure 1. Research Method Flow Chart 9
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 12
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2020-2027 14
Figure 4. North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market, 2017-2027, $ mn 16
Figure 5. Impact of COVID-19 on Business 19
Figure 6. Primary Drivers and Impact Factors of North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market 21
Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 24
Figure 8. Primary Restraints and Impact Factors of North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market 25
Figure 9. Investment Opportunity Analysis 29
Figure 10. Porter’s Fiver Forces Analysis of North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market 32
Figure 11. Breakdown of North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Treatment Type, 2020-2027, % of Revenue 36
Figure 12. Contribution to North America 2021-2027 Cumulative Revenue by Treatment Type, Value ($ mn) and Share (%) 37
Figure 13. North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Medication, 2017-2027, $ mn 38
Figure 14. North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Stem Cell Therapy, 2017-2027, $ mn 40
Figure 15. North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Other Treatments, 2017-2027, $ mn 41
Figure 16. Breakdown of North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market by ALS Type, 2020-2027, % of Revenue 42
Figure 17. Contribution to North America 2021-2027 Cumulative Revenue by ALS Type, Value ($ mn) and Share (%) 43
Figure 18. North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Sporadic ALS, 2017-2027, $ mn 44
Figure 19. North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Familial ALS, 2017-2027, $ mn 45
Figure 20. Breakdown of North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Distribution Channel, 2020-2027, % of Revenue 47
Figure 21. Contribution to North America 2021-2027 Cumulative Revenue by Distribution Channel, Value ($ mn) and Share (%) 47
Figure 22. North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Hospital Pharmacies, 2017-2027, $ mn 48
Figure 23. North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Retail Pharmacies, 2017-2027, $ mn 49
Figure 24. North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Online Pharmacies, 2017-2027, $ mn 50
Figure 25. North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Other Distribution Channels, 2017-2027, $ mn 51
Figure 26. Breakdown of North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Country, 2020 and 2027, % of Revenue 53
Figure 27. Contribution to North America 2021-2027 Cumulative Revenue by Country, Value ($ mn) and Share (%) 54
Figure 28. U.S. Amyotrophic Lateral Sclerosis (ALS) Treatment Market, 2017-2027, $ mn 56
Figure 29. Canada Amyotrophic Lateral Sclerosis (ALS) Treatment Market, 2017-2027, $ mn 58
Figure 30. Amyotrophic Lateral Sclerosis (ALS) Treatment Market in Mexico, 2017-2027, $ mn 60
Figure 31. Growth Stage of North America Amyotrophic Lateral Sclerosis (ALS) Treatment Industry over the Forecast Period 62

List of Tables

Table 1. Snapshot of North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market in Balanced Perspective, 2020-2027 15
Table 2. Growth Rate of World GDP, 2020-2022 18
Table 3. Main Product Trends and Market Opportunities in North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market 28
Table 4. North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Treatment Type, 2017-2027, $ mn 36
Table 5. North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Medication by Type, 2017-2027, $ mn 39
Table 6. North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market by ALS Type, 2017-2027, $ mn 42
Table 7. North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Distribution Channel, 2017-2027, $ mn 46
Table 8. North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Country, 2017-2027, $ mn 53
Table 9. U.S. Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Treatment Type, 2017-2027, $ mn 57
Table 10. U.S. Amyotrophic Lateral Sclerosis (ALS) Treatment Market by ALS Type, 2017-2027, $ mn 57
Table 11. U.S. Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Distribution Channel, 2017-2027, $ mn 57
Table 12. Canada Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Treatment Type, 2017-2027, $ mn 59
Table 13. Canada Amyotrophic Lateral Sclerosis (ALS) Treatment Market by ALS Type, 2017-2027, $ mn 59
Table 14. Canada Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Distribution Channel, 2017-2027, $ mn 59
Table 15. Mexico Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Treatment Type, 2017-2027, $ mn 61
Table 16. Mexico Amyotrophic Lateral Sclerosis (ALS) Treatment Market by ALS Type, 2017-2027, $ mn 61
Table 17. Mexico Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Distribution Channel, 2017-2027, $ mn 61
Table 18. AB Science SA: Company Snapshot 66
Table 19. AB Science SA: Business Segmentation 66
Table 20. AB Science SA: Product Portfolio 67
Table 21. AB Science SA: Revenue, 2017-2019, $ mn 67